Treating status epilepticus in clinical practice-a multi-national survey in Germany, Austria, and Switzerland.
Frontiers in Neurology · 2025-01-01 · Observational study
Abstract
BACKGROUND: Status epilepticus (SE) is a life-threatening neurological emergency, and exhibits significant variability in clinical management despite established guidelines. This study evaluates current practices across German speaking countries. METHODS: A web-based survey (December 2023-May 2024) assessed SE treatment strategies among 83 neurologists and neurointensivists from Germany, Austria, and Switzerland. Cases were presented to analyze diagnostic and therapeutic preferences. RESULTS: The preferred benzodiazepine for first line treatment was lorazepam, chosen by 71.6% of the respondents. In the case of established SE, 35.4% chose levetiracetam as the preferred ASM. Propofol in combination with sufentanil/fentanyl was the preferred anesthetic of choice in 65.4% of respondents. For super-refractory status epilepticus (SRSE), 41.5% prefer to add further ASM, with valproic acid (67.1%), and lacosamide (64.5%) being the most frequently selected. Only 31.8% reported that their emergency services have a standard operating procedure (SOP) for SE treatment, and the choice of the preferred benzodiazepine varied in the preclinical setting, with midazolam being the most commonly used. 1) First-line therapy: Lorazepam (71.6% in-hospital), midazolam (50% prehospital), 2) Second-line therapy: Levetiracetam (35.4%) and lacosamide (13.4%) were the most common choices, 3) Refractory SE: Propofol with opioids (65.4%) were preferred for anesthesia, 4) Prehospital care: 31.8% of emergency services lacked standardized protocols; midazolam dosing varied widely (2-10 mg). DIAGNOSTICS: Laboratory testing was universal (96.9%), but MR-imaging (10%) and clinical use of prognostic scores (6.2%) were underutilized. CONCLUSION: This survey highlights the variability in clinical practice for managing status epilepticus in German-speaking countries. Persistent heterogeneity in SE management underscores the need for standardized protocols, particularly in prehospital care and refractory SE therapy.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Anaesthetics · Analgesics · Other benzodiazepines & Z-drugs · Fentanyl · Implementation · Midazolam · Propofol · Sedatives & anxiolytics
Related articles
- Italian Intersociety Recommendations on pain management in the emergency setting (SIAARTI, SIMEU, SIS 118, AISD, SIARED, SICUT, IRC). (Minerva Anestesiol, 2015)
- [S2k guidelines: status epilepticus in adulthood : Guidelines of the German Society for Neurology]. (Nervenarzt, 2021)
- Changes in anaesthetic use for trauma patients in German HEMS - a retrospective study over a ten-year period. (Scand J Trauma Resusc Emerg Med, 2019)
- Maintenance of prehospital anaesthesia in trauma patients: inconsistencies and variability in practice. (BJA Open, 2025)
- Anesthesia and analgesia protocol during therapeutic hypothermia after cardiac arrest: a systematic review. (Anesth Analg, 2010)
- Propofol and remifentanil versus midazolam and fentanyl for sedation during therapeutic hypothermia after cardiac arrest: a randomised trial. (Intensive Care Med, 2012)